Literature DB >> 3689007

Gastrointestinal sarcomas. Analysis of prognostic factors.

P C McGrath1, J P Neifeld, W Lawrence, S Kay, J S Horsley, G A Parker.   

Abstract

Clinical and pathologic data from 51 patients with primary sarcomas of the gastrointestinal tract treated from 1951 through 1984 were reviewed to determine clinical presentation, histologic features, treatment, and prognostic factors. The most common signs and symptoms were abdominal pain (62%), gastrointestinal bleeding (40%), and/or abdominal mass (38%). The primary site was stomach in 50%, small bowel in 30%, colorectum in 15%, and esophagus in 5%. Virtually all the sarcomas were leiomyosarcomas. Distribution was uniform among the three histologic grades; although 88% of Grade 1 tumors could be completely excised, only 35% of Grade 3 tumors could be completely resected. The 5-year survival rate was 75% for Grade 1 tumors, 16% for Grade 2 tumors, and 28% for Grade 3 tumors (p = 0.0013, Grade 1 vs. 2 and 3). Thirty of the 51 patients (59%) had curative resection with an operative morbidity rate of 24% and an operative mortality rate of 12%; at 5 years the disease-free survival rate was 58% and the overall survival rate was 63% (48% at 10 years). Eleven patients (42%) had recurrent disease develop at a median interval of 2 years after complete tumor excision. Twenty-one patients (41%) had partial excision or biopsy only of their tumors with an operative morbidity rate of 28%, operative mortality rate of 8%, and median survival of only 9 months. Overall, patients whose tumors were confined to the site of origin had a 58% 5-year survival rate compared with 20% for those whose tumors had invaded adjacent organs (p less than 0.05). If the tumor was less than 10 cm in size, the 5-year survival rate was 78%, significantly better than the 38% for tumors greater than 10 cm (p = 0.03). These data suggest that histologic grade, local invasiveness, size, and extent of resection are the most important prognostic factors for patients with primary gastrointestinal sarcomas. Patients who have resection of all gross tumor, especially if it is well differentiated and localized, have a good prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3689007      PMCID: PMC1493319          DOI: 10.1097/00000658-198712000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  SMOOTH MUSCLE TUMORS OF THE ALIMENTARY TRACT.

Authors:  J E SKANDALAKIS; S W GRAY
Journal:  Prog Clin Cancer       Date:  1965

2.  Leiomyomas and leiomyosarcomas of the small intestine.

Authors:  G F STARR; M B DOCKERTY
Journal:  Cancer       Date:  1955 Jan-Feb       Impact factor: 6.860

3.  Prognostic variables in pediatric rhabdomyosarcoma before and after multi-modal therapy.

Authors:  J P Neifeld; H M Maurer; D Godwin; J W Berg; A M Salzberg
Journal:  J Pediatr Surg       Date:  1979-12       Impact factor: 2.545

4.  Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years.

Authors:  H L Evans
Journal:  Cancer       Date:  1985-11-01       Impact factor: 6.860

5.  Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma).

Authors:  H D Appleman; E B Helwig
Journal:  Cancer       Date:  1976-08       Impact factor: 6.860

6.  Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: a pathologic analysis of 100 cases.

Authors:  M Ranchod; R L Kempson
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

7.  Sarcoma of the stomach: clinicopathologic study of 43 cases.

Authors:  A Y Bedikian; N Khankhanian; M Valdivieso; L K Heilbrun; R S Benjamin; B S Yap; R S Nelson; G P Bodey
Journal:  J Surg Oncol       Date:  1980       Impact factor: 3.454

Review 8.  Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn't know.

Authors:  H D Appelman
Journal:  Am J Surg Pathol       Date:  1986       Impact factor: 6.394

9.  Leiomyosarcoma of the small and large bowel.

Authors:  O E Akwari; R R Dozois; L H Weiland; O H Beahrs
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

Review 10.  Leiomyosarcoma of the gastro-intestinal tract: general pattern of metastasis and recurrence.

Authors:  Y T Lee
Journal:  Cancer Treat Rev       Date:  1983-06       Impact factor: 12.111

View more
  46 in total

Review 1.  Synchronous colorectal adenocarcinoma and gastrointestinal stromal tumor (GIST).

Authors:  Marcovalerio Melis; Eugene A Choi; Robert Anders; Peter Christiansen; Alessandro Fichera
Journal:  Int J Colorectal Dis       Date:  2006-04-26       Impact factor: 2.571

2.  NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Cristina R Antonescu; Ronald P DeMatteo; Kristen N Ganjoo; Robert G Maki; Peter W T Pisters; Chandrajit P Raut; Richard F Riedel; Scott Schuetze; Hema M Sundar; Jonathan C Trent; Jeffrey D Wayne
Journal:  J Natl Compr Canc Netw       Date:  2010-04       Impact factor: 11.908

3.  Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.

Authors:  Martin D McCarter; Cristina R Antonescu; Karla V Ballman; Robert G Maki; Peter W T Pisters; George D Demetri; Charles D Blanke; Margaret von Mehren; Murray F Brennan; Linda McCall; David M Ota; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2012-07       Impact factor: 6.113

4.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

5.  Sporadic somatic mutation of c-kit gene in a family with gastrointestinal stromal tumors without cutaneous hyperpigmentation.

Authors:  Chun-Nan Yeh; Tsung-Wen Chen; Yi-Yin Jan
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

6.  Surgical margin status and prognosis of gastrointestinal stromal tumor.

Authors:  António M Gouveia; Amadeu P Pimenta; Ana F Capelinha; Dionísio de la Cruz; Paula Silva; José M Lopes
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

7.  Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.

Authors:  Haluk R Unalp; Hayrullah Derici; Erdinc Kamer; Ali D Bozdag; Ercument Tarcan; Mehmet A Onal
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

8.  Colorectal gastrointestinal stromal tumors: a brief review.

Authors:  Rishindra M Reddy; James W Fleshman
Journal:  Clin Colon Rectal Surg       Date:  2006-05

9.  Colorectal sarcoma: more than a gastrointestinal stromal tumor.

Authors:  C Randall Cooper; Brendan F Scully; Steven Lee-Kong
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-16

Review 10.  Multidisciplinary treatment of gastrointestinal stromal tumors.

Authors:  T Peter Kingham; Ronald P DeMatteo
Journal:  Surg Clin North Am       Date:  2009-02       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.